Gradient line
BioTransfer 2009   |   Contacts   
Gradient line
button Home button Co-organizers button Partners button Program button Registration bouton Networking button Portfolio
Gradient line

Co-organizers Technology Portfolio

Co-organizers
NRC Biotechnology Research Institute (NRC-BRI)
NRC Institute for Biological Sciences (NRC-IBS)
McGill University and the Research Institute of the McGill University Health Centre   Montreal Excellerator
Gestion Univalor, Limited Partnership   Université de Montréal and Affiliated Hospital Centres
The Massachusetts Technology Transfer Center

Co-organizers Technology Portfolio Login


NRC Biotechnology Research Institute (NRC-BRI)
Technology Portfolio
ID #TitlePDFVideoInformation Request
NRC-BRI 12020 SHOWCASE: Cancer Prognostic Markers and the Method for Finding Them
NRC-BRI 11993 SHOWCASE: Production of Glycosylated Interferon a2b forBiogeneric Application
NRC-BRI 11992 SHOWCASE: Efficient, Fast and Productive Method for Large-Scale Transfection of CHO and HEK293 Cells
NRC-BRI 11947 Novel gene expression system for Escherichia coli
NRC-BRI 11887 SHOWCASE: Muscle-Mediated Gene Therapy
NRC-BRI 11885 Potent VEGF Antagonists as a PromisingAnti-Cancer Therapy
NRC-BRI 11864 D-isoproterenol as an Anti-Diabetic Cataract Compoundand for Delaying Formation of Retinopathy
NRC-BRI 11817 SHOWCASE: TGF-β Biologic Targeted Therapy for Oncology, Cardiovascular Disease and Nephrology Indications
NRC-BRI 11770 Enhanced system for baculovirus-mediated transient transgene expression
NRC-BRI 11727 Macrophage genes regulated by Ganoderma lucidum
NRC-BRI 11725 Powerful Methylobacterium-based technology platform for the production of recombinant proteins and other bioproducts
NRC-BRI 11622 A physical method for the quantification of viruses and viral particles
NRC-BRI 11615 Biomolecular Tweezers,a Protein-Protein Interactions
NRC-BRI 11565-PL HEK293 mammalian cell platform for high yield production of recombinant proteins, vaccines, and viral vectors
NRC-BRI 11565 Optimized large-scale transient gene expression with a serum-free suspension-growing HEK293 cell line
NRC-BRI 11498 Generating re-targeted adenoviral vectors with altered tropism
NRC-BRI 11444 A novel rapid and sensitive on/off switch regulated by coumarin for gene expression in mammalian cells
NRC-BRI 11404 Protein expression technologies
NRC-BRI 11391 Novel carrier proteins derived from Staphylococcus nuclease for high yield peptide production
NRC-BRI 11388 Potent anticoagulants based on peptide inhibitors of thrombin
NRC-BRI 11323 Eye drops for the delivery of an anti-glycation agent that prevents and treats diabetes- and age-related pathologies
NRC-BRI 11320 Versatile and sterilizable probe for the extraction and quantification of volatile compounds in liquids
NRC-BRI 11266 Fast and high yield recombinant proteins production by large-scale transfection of suspension-growing mammalian cells
NRC-BRI 10894 SHOWCASE: HEK293 Cell Line for Industrial Production of Recombinant Proteins, Viral Vectors and Vaccines
NRC-BRI 10890 Efficient generation of adenovirus-based libraries by positive selection of adenoviral recombinants
NRC-BRI 10624 Simple and efficient method for the large-scale production of E1 deficient adenovirus
NRC-BRI 10269 Method for high-yield enzymatic synthesis of non-ionic biosurfactants
NRC BRI 11648 SHOWCASE: Cumate-inducible expression system in eukaryotic cells
blank spaceFooter Line
 
Date Modified: 2009-12-04
Top of page